Paolo Mannelli is a Psychiatry physician affiliated with Duke Medical Center. OpenAlex indexes 126 publications with 3,124 citations (h-index 32); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2100 Erwin Rd
Durham, NC 277100001
Telephone
919-620-4467Registry record last updated 27 Aug 2013.
Clinical trials
- Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence
Sponsor: Paolo Mannelli
- Addition of Naltrexone to Methadone Taper
Sponsor: National Institute on Drug Abuse (NIDA)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Indivior Inc.Program year202510 payments
- Indivior Inc.Program year20237 payments
- Indivior Inc.Program year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
2 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Targeting Reinforcement Mechanisms for Smoking Cessation Using Very Low Nicotine Content Cigarettes in Individuals with Opioid Use Disorder and Chronic Pain
Duke University
FY2026$241,500R34DA060477 - Targeting Reinforcement Mechanisms for Smoking Cessation Using Very Low Nicotine Content Cigarettes in Individuals with Opioid Use Disorder and Chronic Pain
Duke University
FY2025$241,500R34DA060477 - Targeting Reinforcement Mechanisms for Smoking Cessation Using Very Low Nicotine Content Cigarettes in Individuals with Opioid Use Disorder and Chronic Pain
Duke University
FY2024$241,500R34DA060477
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.
Addiction Science & Clinical Practice
2023 - Review of Popularity and Quality Standards of Opioid-Related Smartphone Apps
Current Addiction Reports
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Abbruzzese, MD
Duke Medical Center
David Durack, MD
Duke Medical Center
Leonard Prosnitz, MD
Duke Medical Center
Scott Cousins, MD
Duke Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”